|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/32 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 1771482 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05818254.4 |
| Date of filing the European patent application | 2005-07-15 | |
| (97) | Date of publication of the European application | 2007-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (86) | Number | PCT/US2005/025084 |
| Date | 2005-07-15 |
| (87) | Number | WO 2006/033700 |
| Date | 2006-03-30 |
| (30) | Number | Date | Country code |
| 590202 P | 2004-07-22 | US |
| (72) |
KAO, Yung-Hsiang, US
VANDERLAAN, Martin, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | HER2 antikūno kompozicija |
| HER2 ANTIBODY COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2024-06-19 | 347.00 EUR |